Guri et al. observed that the supplementation with dietary ABA ameliorated the disease and colonic inflammatory lesions in experimental inflammatory bowel disease through a T cell PPARγ-dependent mechanism [43]. This evidence concerns the gene PPARG and inflammatory bowel disease.